A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis

BACKGROUND: Patients with ankylosing spondylitis (AS) are at increased risk of developing inflammatory bowel disease (IBD). We aimed to determine the variation in fecal calprotectin in AS over 5 years in relation to disease activity and medication and also to study the incidence of and predictors fo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Arthritis Res Ther
Autores principales: Klingberg, Eva, Strid, Hans, Ståhl, Arne, Deminger, Anna, Carlsten, Hans, Öhman, Lena, Forsblad-d’Elia, Helena
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5289027/
https://ncbi.nlm.nih.gov/pubmed/28148281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1223-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares